Risk Metrics: How to See Health Problems Before Health Starts to Break Down

Health is not a “normal / abnormal” switch. It is also not the mere absence of disease according to the World Health Organization definition. It is a system of risks that is always moving. Most serious problems do not begin with symptoms, but with small shifts in lab results, worsening trends, and quiet changes inside the body that are easy to miss.

That is why I’m less and less interested in the question “am I already sick or not yet?” and more interested in “where is risk already forming, and where is it moving?” In this article, I want to show why the word “normal range” is not enough, how to read signals not through one number but through a system, and why a more adult logic of health begins not with diagnosis, but with reading the trajectory early.

A Quick Note on the Medical Review

Parts of this article touch on medical concepts, biomarkers, and long-term health risks. Because of that, some sections may sound slightly more technical than the rest of the site.

I wrote this myself — as someone building a practical system, not practicing medicine. Although after several months in PubMed, the line starts to blur. To avoid accidentally diagnosing myself with something extra, I asked a medical doctor to review the text. He corrected a few formulations and reminded me where analytics ends and medicine begins. If some paragraphs feel slightly more clinical than the rest of the site — that is his doing, not my freelancing.

---

Why “Normal” Does Not Mean Everything Is Fine

One of the most deceptive words in medicine is “normal.”

You do your tests, see green values, and think: alright, we live. That reaction is understandable. But it is often too relaxing.

The problem is that “normal” is not a guarantee of safety. It does not mean “everything is excellent.” It does not even mean “everything is optimal.” It only means the marker has not yet fallen outside the lab range.

And a lab range is not an ideal. It is a statistic. Put simply, if a large number of people already have excess weight, poor sleep, insulin resistance, inflammation, and early chronic problems, then the middle of that population is not exactly where you want to aim with enthusiasm.

That is why a green number on a lab sheet is not a medal.

You can have glucose that still falls within the “normal” range, but has already been creeping upward for several years. You can have cholesterol that alarms no one, while your real vascular risk is already rising. You can have liver markers without red flags, while inside the system is already developing subtle metabolic changes. That is what I like about Peter Attia: he keeps returning to one simple idea — disease almost never begins on the day you are diagnosed. A diagnosis is often not the beginning of the story. It is the moment when the system finally bothers to admit that the story has been already underway for a long time.

A simple example: if someone has an HbA1c of 6.5, that is already type 2 diabetes. If it is 6.4, officially it is not. But biology is not sitting there with a calculator saying, “Right, everything was fine up to 6.4, and now we start breaking down.” The process started earlier.

The same is true for atherosclerosis. It usually develops over years. Often decades. Not after one fatty dinner and not after three days on holiday. One day a person simply finds out about a problem that has been already forming for a very long time.

That is why the word “normal” does not reassure me. This does not mean every normal test is bad. It means that one normal test is far too little to conclude there is no risk.

What matters much more is:

• where the marker sits within the range
• where it was a year ago
• where it is moving
• which other markers sit next to it
• what is happening at the same time with waist size, blood pressure, body composition, lifestyle, sleep, and family history

That is already a more adult conversation.

---

The Shift: From “What Do I Have Right Now?” to “Where Is This Going?”

At first glance the difference seems small, but in practice it changes everything. Once you stop thinking in terms of “healthy / unhealthy” and start thinking through risk, tests stop being just a piece of paper for reassurance. A blood test is no longer about “let’s see if everything still looks decent,” screening is no longer only for when something already hurts, and a check-up is no longer a formality for the sake of ticking a box.

All of this starts to have a clear practical meaning: to notice a breakdown before it becomes expensive, obvious, and unpleasant.

If you simplify it, it is like a car. I can say: “Well, it’s still driving, so everything must be fine.” But if you look a little deeper, the questions change:

• is it losing oil?
• is the engine overheating?
• has fuel consumption gone up?
• are there any strange noises?
• is the suspension starting to wear out?

A car can keep moving while slowly falling apart at the same time. The body is the same.

This is not about doctors not understanding something. The system is simply built around acute situations: trauma, infection, obvious symptoms, a clear diagnosis — cases where you need to react quickly and save the person. But chronic diseases work differently: they do not arrive dramatically, they build unnoticed.

That is where a more useful model appears — one built around risk. In that model, numbers are not answers, but clues. You stop looking at one marker in a vacuum and start asking a chain of questions.

If we take the metabolic story, the issue is no longer only whether glucose is “normal.” It is multi-factorial — insulin, triglycerides, waist size, liver function, visceral fat, activity, and body composition over the last few years.

The same is true for cardiovascular risk: LDL is only part of the picture. But what about apoB? Is there Lp(a)? What is blood pressure doing? What is the family history? What does the calcium score show? Is there inflammation? And what is lifestyle doing to the whole system?

At that point, you stop reading isolated numbers. You start reading a process.

That is where the line sits between a superficial approach and real health management.

Wellness asks: “How do I feel?” Medical practice often emphasizes “what is your diagnosis?” Risk management asks: “What is already moving under the surface?”

And that is exactly why trend, factor combinations, and direction of movement are almost always more important than one isolated number.

---

The Four Horsemen of Death

In Outlive, Peter Attia offers a very useful framework — the Four Horsemen.

These are four large groups of problems people most often drift toward as they age:

• cardiovascular disease
• cancer
• neurodegenerative disease
• metabolic dysfunction

I like this model because it removes the sense of chaos. We like to talk about health in terms that are far too vague. Something like, “you just need to take care of yourself.” It sounds noble and is completely useless.

Here the picture is harsher and more honest: most serious problems of aging do not come from a thousand random directions, but from four fairly clear ones.

Cardiovascular Disease

This is not just “heart pain.” It is atherosclerosis, plaque, vascular problems, heart attacks, strokes, and everything that slowly builds around them.

The main problem is that these diseases often move silently. A person can live an ordinary life for years and then suddenly meet a heart attack. Despite how sudden the event looks, the process almost never is.

Cancer

The problem here is similar: cancer is often found too late because the body can give no signal for a long time — sometimes far too long. In real life, managing cancer risk is not about “hoping you get lucky,” but about screening, family history, and a willingness not to wait for symptoms.

For me, this is not an abstract topic. My father died at 55 — four days after he was diagnosed with cancer. And the strangest part of that story was not even the shocking event itself, but the prevailing sentiment within the community: when I asked how that could happen, the common response was a calm: “55 is normal.”

For me, it is not. And it still is not.

I do not consider dying at 55 normal. And that is exactly why, for me, cancer risk is not a “someday later” story, but an area where it matters not to wait for symptoms and not to try to catch up with the process at a late stage.

Neurodegenerative Disease

This block is frightening because it hits not only the body, but the person. Memory, thinking, independence, the ability to make decisions — all of that can erode slowly. And the worst part is that by the time the problem becomes noticeable, the process has often been underway for a long time.

I grew up on Bruce Willis films, and for a long time he was an icon for me. Now, looking at his situation, I understand one thing more and more clearly: the last thing in life I would want is to lose my mind.

Because at some point, you are not just losing health. You are losing yourself.

And that is why one thing becomes completely obvious: the brain is the main organ worth protecting first. Working with risk in this area is not something for “later.” It is part of a systematic approach to a long life.

Metabolic Dysfunction

This is the quietest and most underestimated block. Metabolic health is not just “blood sugar,” but how well the body can work with energy: how it manages glucose, how it responds to insulin, what is happening with fats, and where exactly that fat is being stored.

When this system starts to drift, problems do not arrive one by one — they come trailing behind each other.

And this is no longer abstract theory. It is a fairly direct observation: we rarely die by accident — more often we slowly move toward one of these scenarios.

It sounds harsh. But it is honest.

---

How I Break Risk Down as a System

So that all of this does not look like a chaotic folder full of lab reports, I broke risk into four blocks:

• Lab Tests
• Heart Risk
• Metabolic Health
• Screening

This is not a medical classification from a textbook. It is my working model.

I need a simple, understandable system that helps me see:

• where risk is building up
• what kind of risk it is
• where I need to look first

Lab Tests — Signals, Not Answers

Lab tests are the first layer. They give signals, not final answers. Not ultimate truth and not a diagnosis — just signals. And that is already a lot.

Most people start with lab tests, and that makes sense: they are accessible, understandable, the numbers look convincing, and it feels like everything should become clear. But in practice, a standard panel is often too crude if you read it superficially.

What matters is not one marker and not one beautiful number, but a system of markers that are read together.

That is why I look at lab data not as a pile of separate tests, but as several blocks:

• lipids and vascular risk
• glucose, insulin, and metabolic health
• liver
• inflammation
• kidneys
• thyroid
• iron, vitamins, and other deficiencies
• hormonal background and additional markers depending on the situation

There are markers that standard medicine often does not include in the default habit of checking. First of all, that includes apoB, Lp(a), fasting insulin, and a more careful reading of metabolic and lipid markers in trend, not only through the logic of “inside the range or outside it.”

So the point is not to test everything at random. The point is to build a working panel that shows early shifts in the system.

Numbers without context are noise. But properly grouped markers already become a map of risk.

Heart Risk — A System, Not One Marker

If there is one area where people calm down too quickly, it is the heart and blood vessels. People still talk about cholesterol the way they talk about the weather: “good,” “bad,” “looks alright.” That is not enough.

Cardiovascular risk is not one marker, but a whole structure. Yes, a regular lipid panel matters, but without a broader picture it often gives a very shallow impression.

What really matters:

• apoB — in many ways the central marker. The problem is not that “there is cholesterol somewhere,” but how many potentially harmful particles keep hitting vessel walls for years.
• Lp(a) — a very unpleasant player. It is an inherited cardiovascular risk factor that can sit in the shadows for a long time.
• blood pressure — boring, but critical. Slightly elevated blood pressure over years is not a “hot temperament,” but constant strain on the vessels.
• family history — if there were early heart attacks or strokes in the family, your numbers cannot be read with the same naivety.
• imaging — sometimes the conversation changes for real only after a scan. For example, coronary artery calcium scoring can show that there is already built-up damage in the vessels, even when the blood work looked acceptable.

There was a separate shift for me here. For a long time, like many people, I focused on foods with “low cholesterol” — it seemed logical that this would directly reduce risk. But the data shows a more complicated picture. This does not mean nutrition is unimportant. It means that risk is not determined by one food, but by how the whole system works — metabolism, inflammation, lifestyle, and genetics.

That is why Heart Risk is not only “cholesterol.” It is: apoB, Lp(a), blood pressure, family history, inflammation, imaging, lifestyle, and the amount of time all of that has had to do its work.

The system matters more than one number.

Metabolic Health — How the Body Manages Energy

This is the block that seems boring right up to the point where it starts damaging everything else.

Metabolic health is not a subject only for people with excess weight. It is not just “don’t eat sweets after six.” And it is definitely not only about diabetes. It is the question of how well the body handles fuel.

What to look at:

Fasting glucose — Useful. But not enough.

HbA1c — Also useful. But often no longer an early signal.

Fasting insulin — This is often where the real depth begins. If glucose is still “normal” but insulin is already rising, it can mean the body is already working under strain to keep the picture looking decent.

Triglycerides and HDL — Taken separately, they are not ideal. Together, they can hint at what the metabolic picture looks like.

Liver — The metabolic story often passes through the liver before a person even realizes it.

Waist size and visceral fat — This is where appearance starts to lie. You can look “more or less fine,” while already accumulating visceral fat that behaves in a very toxic way.

The main idea here is simple: metabolic breakdown moves slowly and quietly. It does not arrive like a dramatic collapse. It arrives as drift.

• a little more abdominal fat
• slightly worse energy
• slightly worse recovery
• slightly higher glucose
• slightly more liver fat
• slightly higher insulin
• slightly less resilience

That is exactly why it is so easy to underestimate.

Screening — What Blood Cannot Show

Blood tests show only signals when taken alone. Screening shows reality. Even though blood tests are a vital component of medical screening, acting as both a primary diagnostic tool and a necessary supplement to advanced imaging, a comprehensive health assessment requires moving beyond these markers. Because blood is not X-ray vision. It can hint, warn, and signal, but it cannot directly show how much visceral fat is actually inside, what body composition really looks like, whether vascular calcification has already started, whether organs have changed structurally, or whether an important cancer screening has been missed.

That is where Screening becomes very useful.

Many people still think of DEXA as something for fitness enthusiasts, but that is too narrow. DEXA helps show how much fat you have, how much muscle, what is happening with bone, and how fat is distributed — and that is far more useful than a single number on the scale. Weight can stay the same while the body has already become something very different.

Ultrasound is a practical, understandable, and often fairly accessible way to look at the liver, gallbladder, kidneys, thyroid, and sometimes the vessels. That is no longer about assumption, but about structure.

CAC and other imaging methods matter too. In the cardiovascular world, calcium scoring can sometimes show reality much more honestly than a “normal LDL.”

Cancer screening is its own adult category. Colonoscopy, mammography, skin checks, PSA discussions, and other age-based screenings are normal risk-management logic.

When I talk about Screening, I do not mean chaotic hunting for tests. I mean DEXA for body composition, ultrasound where structure matters, targeted imaging when risk justifies it, and early cancer screening based on age and history.

Because at some point, it becomes important to stop asking: “What do the lab results suggest?” And start asking: “What is actually going on inside?”

---

My Current Risk Map

I have not completed the whole Risk Metrics system yet — some tests and lab work are still ahead, and on Bali it is not always easy to do everything I need. Most likely, I will do part of the screening in other countries and then add the results here. But even with the data I already have, the picture is beginning to take shape.

If I simplify it, right now it looks like this.

Status	Area	What is happening	How I read it
OK ✅	Glucose	Blood sugar remains stable, no signs of diabetes	The system is coping for now; there are no obvious glucose-related metabolic failures
OK ✅	Liver	Blood work and ultrasound show no signs of overload	No clear structural or functional problem
OK ✅	Tumor markers	Basic markers show no deviations	No clear signal, but that does not cancel regular screening
OK ✅	General biochemistry	No critical deviations	No sense of obvious systemic breakdown
Not OK 🚨	Vessels and heart	Cholesterol is outside the optimal range, there are signs of atherosclerosis	For me, this is no longer theory but a signal that risk needs deeper work
Not OK 🚨	Brain	Early signs of wear in small vessels	No symptoms yet, but already an area of focus if I want to protect cognitive function
Not OK 🚨	Thyroid	The immune system has started attacking the organ	Function is holding, but this needs monitoring and closer reading in trend
Not OK 🚨	Metabolism	Excess fat and strain on the system	Not critical, but no longer optimal for a long game
Not OK 🚨	Bilirubin	Periodically elevated	A recurring signal that needs to be read in the broader picture

I am not at the point of “I have a disease.” I am at the point where several early processes are already visible. And the task in front of me is clear: not to wait until they become diagnoses, but to gather the missing data, close the blind spots, and start managing the risks systematically while there is still time to turn things back the other way.

---

Where People Usually Fall Behind

The most common mistake is waiting until risk becomes an official problem.

Waiting until a marker goes outside the reference range. Waiting until symptoms appear. Waiting until a doctor can call it a diagnosis rather than a tendency.

But chronic disease does not work like that. It does not begin when the system finally stamps it as official. By then the process is already underway. Sometimes it has been for a long time.

So the weak version sounds like this: “Until it becomes officially bad, everything is fine.”

The stronger version sounds different: “If the process is already visible, then it is already something to work on.”

That is where the line sits between passive observation and actual risk management.

Because the problem is almost never one bad number. The problem is that:

• one marker slowly drifts the wrong way
• a second one worsens next to it
• then a third joins in
• and a few years later it gets called a “sudden” diagnosis

There is only a trajectory that was ignored for too long.

---

What the Research Says

None of what I described above is personal invention. The research backs it up — and that matters to me, because I am not interested in building a system on intuition alone.

Chronic diseases rarely begin at diagnosis. They develop gradually, often over many years, before becoming clinically visible. Tabák et al. (The Lancet, 2012) documented this well in the context of prediabetes — a state that can exist for a long time before the official threshold is crossed.

Atherosclerosis follows the same logic. Libby et al. (Nature, 2011) describe it as a process that forms over decades while remaining completely asymptomatic. The event feels sudden. The process was not.

On the cardiovascular side, apoB and Lp(a) matter because they reflect something more precise than standard cholesterol: the actual number of atherogenic particles and inherited risk that a lipid panel can easily miss. Ference et al. (European Heart Journal, 2017) and Tsimikas & Witztum (Nature Reviews Cardiology, 2024) make that case clearly.

Visceral fat is where the metabolic story often starts — long before glucose or HbA1c move. Després et al. (Circulation, 2012) has spent decades showing how central visceral fat is to insulin resistance and cardiometabolic dysfunction.

And when blood work looks acceptable but risk is still building, imaging fills the gap. CAC scoring can detect subclinical atherosclerosis that labs simply cannot see — a point well supported by ACC/AHA guidelines.

The through-line across all of it: risk is a system. Trend, combinations, and trajectory matter more than any single number at any single point in time.

---

Why This System Matters at All

This system is not there to turn me into an anxious man with a folder full of lab reports.

It is there to help me see expensive scenarios earlier. Not when the problem has already fully formed, but when it is still reversible, still relatively cheap to correct, and has not yet settled into life as the new normal.

That is the practical meaning of Risk Metrics.

Not to collect more numbers. Not to be impressed by a beautiful check-up. Not to play biohacking for the illusion of control.

But to do three things:

• notice an early shift
• understand what kind of risk it belongs to
• decide what to do next: watch, clarify, change behaviour, or go deeper into screening

So this is not about a cult of measurement. It is about reducing the probability of delayed surprises.

---

Conclusion

If I simplify it as much as possible, the point of this section is this: health is better read as a process, not a status.

Not “sick / not sick.” Not “normal / abnormal.” But: what is already changing, where is it going, and how much does it resemble the start of a bigger problem?

That is why the risk model makes more sense to me than the reassurance model. It disciplines the way I think. It forces me to look at trends, factor combinations, and the structure of risk. It helps me step in earlier, before the body starts explaining everything through symptoms. The body does communicate — just vividly and at a price I would rather not pay.

In the end, the task is simple: not to wait until it becomes obvious, but to learn to notice earlier.

---

Medical Review

This article was reviewed by a medical professional for accuracy and alignment with current medical evidence. Last reviewed: April 5, 2026.

Tsegab Bukate, MD, MPHA Medical Doctor, Published Clinical Researcher, and Preventive and Public Health Expert. LinkedIn Profile

---

Disclaimer

I am not a doctor. I am an entrepreneur who decided to stop guessing and start measuring — and this article is a record of that process, not a clinical prescription.

Everything here reflects my personal experience, the way I read research, and the system I am building for myself. It is not medical advice. It is not a substitute for a doctor. And it is definitely not a recommendation to copy what I do without thinking.

If something in this article resonates — good. But any decisions about lab work, screening, medication, or lifestyle changes worth making should go through a qualified physician who actually knows your situation. Not through a blog post written by a guy in Bali.